The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) issued on 19 September 2022 a joint statement confirming that biosimilar medicines approved in the European Union (EU)...
More >
FORO LATINOAMERICANO DE ESTA SEMANA
Nomenclature of biologicals and biosimilars in Peru
Posted 20/05/2022
This article, the last in a series on the nomenclature of biological and biosimilar med...
Brazilian market of biosimilars
Posted 20/05/2022
As the largest country in South America, Brazil is an important market for the pharmace...
WHO revised guidelines for biosimilars: scientific background
Posted 08/07/2022
A study carried out by Kurki P et al. in 2022 reviewed the current clinical experi...
Nomenclature of biologicals and biosimilars in Peru
Posted 20/05/2022
This article, the last in a series on the nomenclature of biological and biosimilar med...
Brazilian market of biosimilars
Posted 20/05/2022
As the largest country in South America, Brazil is an important market for the pharmace...
WHO revised guidelines for biosimilars: scientific background
Posted 08/07/2022
A study carried out by Kurki P et al. in 2022 reviewed the current clinical experi...
Home/Non‐Biological Complex Drugs
FDA issues final guidance on liposome drug products
Posted 27/04/2018
0
On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...
More >
